Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
CD 4+ T cells in the pathobiology of neurodegenerative disorders
Journal of Neuroimmunology, 06/24/09
Huang X et al. - CD4+ T cells orchestrate innate and adaptive immunity. In the central nervous system they modulate immune responses including cell trafficking and glial neuroregulatory functions through an array of soluble molecules cell–cell interactions affecting tissue homeostasis. During disease their roles evolve to an auto-aggressive or, alternatively, protective phenotype. How such a balance is struck in the setting of neurodegenerative disorders may reflect a dichotomy between regulatory T cell, anti-inflammatory and neuroprotective activities versus effector T cell inflammation and neurodegeneration. Interestingly, such roles may show commonalities amongst neurodegenerative diseases. Herein the authors focus on strategies to modulate such CD4+ T cell responses for therapeutic gain.
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Therapeutic Advances in Neurological Disorders, 11/10/09
The management of allergic eye diseases in primary eye care
Contact Lens and Anterior Eye, 11/03/09
Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Archives of Neurology, 11/19/09
Sponsor
Article Search
Sponsor


See Latest Articles


